<p>Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease. Jo Cheah finds out more from cardiologist John Atherton.</p>

Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease. Jo Cheah finds out more from cardiologist John Atherton.

E139 – SGLT2 inhibitors for kidney and heart disease

The Australian Prescriber Podcast provides a regular dive into some of the many great articles that Australian Prescriber publishes every two months. In each episode, our host will chat with one of the authors from a recent issue of Australian Prescriber.

Share E139 – SGLT2 inhibitors for kidney and heart disease

Sign up to save your podcasts

E139 – SGLT2 inhibitors for kidney and heart disease

E139 – SGLT2 inhibitors for kidney and heart disease

More shows like Australian Prescriber Podcast

All In The Mind

Health Report - Full program podcast

Conversations

Emergency Medicine Cases

The Resus Room

The Good GP

BMJ Best Practice Podcast

If You're Listening

The Zero to Finals Medical Revision Podcast

Primary Care Knowledge Boost

GPnotebook Podcast

What's That Rash?

Dev Raga Personal Finance

Not Stupid

Quick Smart